Former employees at OCR have landed exciting positions in law, investing, entrepreneurship and more. Here are a few of their stories.
Thomas Shrader, Managing Director, Stifel
Thomas Shrader joined Stifel in 2014. Based out of the New York office, Dr. Shrader is a Managing Director in the Healthcare sector, covering Biotechnology. His past awards include the Wall Street Journal’s Best on the Street Survey Award. Before joining Stifel, Dr. Shrader was the Director of Strategic Corporate Partnerships at Yale University and spent a decade as a sell-side analyst, principally at BMO Capital Markets and its predecessors. Dr. Shrader has also been an associate and assistant professor of biochemistry at the Albert Einstein College of Medicine (AECOM) where he directed a laboratory focused on infectious diseases drug target discovery. While at AECOM, he served as an external grant reviewer for the NIH, and was a member of the board of reviewers for a number of journals, including The Journal of Biological Chemistry, Trends in Microbiology, and Genes & Development. Dr. Shrader was a Helen Hay Whitney Fellow at the Massachusetts Institute of Technology, earned a PhD in Molecular Biophysics and Biochemistry from Yale University and a Bachelor of Arts and Sciences degree in Biophysics from The Johns Hopkins University.
John Swartley, Associate Vice Provost for Research and Executive Director of the Penn Center for Innovation at the University of Pennsylvania
John S. Swartley, MBA, PhD is the Associate Vice Provost for Research and Executive Director of the Penn Center for Innovation (PCI) at the University of Pennsylvania (Penn), where he leads a team that is focused on facilitating new product development, venture creation and corporate partnerships based on expertise and technologies created at Penn. Prior to joining Penn in 2007, Dr. Swartley served as Senior Vice President and General Partner of BCM Technologies (BCMT), the venture capital investment subsidiary of Baylor College of Medicine. Dr. Swartley joined BCMT in 2003 from the Yale University Office of Cooperative Research where he was Associate Director of the Medical Campus Office. Over his career, Dr. Swartley has negotiated hundreds of commercialization and research partnership agreements and has participated in the formation and oversight of dozens of university spin-out companies that have collectively raised more than a billion dollars of investment capital. He holds a B.S. in Biology from Bates College, an MBA from the Goizueta School of Business at Emory University, and a PhD in Microbial & Molecular Genetics from Emory University.